ANTIBODY MEDIATED REJECTION AFTER HEART TRANSPLANTATION WITH DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES: CASE REPORT

被引：0
|
作者：
Pashkova, I. A. [1 ]
Porhanov, V. A. [1 ]
Gilevich, I., V [1 ]
Kosmacheva, E. D. [1 ]
Kruberg, L. K. [1 ]
机构：
[1] Krasnodar Reg Hosp, Krasnodar, Russia
来源：
VOX SANGUINIS | 2013年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [31] High incidence of humoral rejection in recipients with de novo donor-specific Anti-HLA antibodies after living-related kidney transplantation.
    Li, Xiaobei
    Ishida, Hideki
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Setoguchi, Kiyoshi
    Toki, Daisuke
    Iida, Shouichi
    Nishida, Hayato
    Tanabe, Kazunari
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 287 - 288
  • [32] Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation
    Cole, Robert Townsend
    Gandhi, Jonathan
    Bray, Robert A.
    Gebel, Howard M.
    Yin, Michael
    Shekiladze, Nikolaz
    Young, An
    Grant, Aubrey
    Mahoney, Ian
    Laskar, S. Raja
    Gupta, Divya
    Bhatt, Kunal
    Book, Wendy
    Smith, Andrew
    Duc Nguyen
    Vega, J. David
    Morris, Alanna A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : 503 - 512
  • [33] CLINICAL SIGNIFICANCE OF LATE ANTIBODY-MEDIATED REJECTION WITHOUT DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Lee, Juhan
    Kim, Eun Jin
    Kim, Soo Jin
    Lim, Beom Jin
    Kim, Beom Seok
    Kim, Myoung Soo
    Kim, Soon Il
    Kim, Yu Seun
    Huh, Kyu Ha
    TRANSPLANTATION, 2020, 104 (09) : S357 - S357
  • [34] Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure, J.
    Lopez-Hoyos, M.
    Rodrigo, E.
    Gomez-Roman, J.
    Ruiz, J. C.
    Arias, M.
    San Segundo, D.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 2888 - 2890
  • [35] Donor-specific anti-HLA antibody mediated rejection in liver transplant recipients
    Dziodzio, Tomasz
    Lachmann, Nils
    Uenlue, Sinem
    Weiss, Sascha
    Chopra, Sascha
    Guel, Safak
    Gerlach, Undine
    Denecke, Christian
    Biebl, Matthias
    Schonemann, Constanze
    Pratschke, Johann
    Oellinger, Robert
    TRANSPLANTATION, 2016, 100 (07) : S244 - S244
  • [36] Characteristics and Clinical Significance of De Novo Donor-Specfic Anti-HLA Antibodies after Kidney Transplantation
    Jung, Hee-Yeon
    Kim, Su-Hee
    Seo, Min-Young
    Cho, Sun-Young
    Yang, Youngae
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Hyung-Kee
    Huh, Seung
    Won, Dong Il
    Kim, Chan-Duck
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (34)
  • [37] De Novo Anti-HLA Class II Donor Specific Antibodies after Lung Transplantation Are Associated with Mortality after Lung Transplant Failure
    Bahar, B.
    Dilling, D. F.
    Du, Z.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S228 - S229
  • [38] Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation
    Li, Xiaobei
    Ishida, Hideki
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2008, 21 (12) : 1145 - 1152
  • [39] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 177 - 177
  • [40] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    TRANSPLANTATION, 2014, 98 : 177 - 177
12345